LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2
Authors:
- 20 August 2018
- journal article
- research article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 22 (4) , 787-797
Abstract
Breast cancer is the most common malignancy in women which increases gradually all over the world. LncRNA GACAT3 has been found to be increased in gastric cancer and associated with tumor malignancy. However, whether GACAT3 plays a role in the regulaKeywords
This publication has 27 references indexed in Scilit:
- Long‐term psychological benefits of cognitive‐behavioral stress management for women with breast cancer: 11‐year follow‐up of a randomized controlled trialCancer, 2015
- Long noncoding RNA HMlincRNA717 and AC130710 have been officially named as gastric cancer associated transcript 2 (GACAT2) and GACAT3, respectivelyTumor Biology, 2014
- Long non-coding RNAs: new players in cell differentiation and developmentNature Reviews Genetics, 2013
- Fas (CD95) expression in myeloid cells promotes obesity‐induced muscle insulin resistanceEMBO Molecular Medicine, 2013
- Breast cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Long Noncoding RNAs: Cellular Address Codes in Development and DiseaseCell, 2013
- A prospective evaluation of a breast cancer prognosis signature in the observational RASTER studyInternational Journal of Cancer, 2013
- Long non-coding RNAs and cancer: a new frontier of translational research?Oncogene, 2012
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- RNA Maps Reveal New RNA Classes and a Possible Function for Pervasive TranscriptionScience, 2007